FST and sarcopenia: As other research suggests that administering follistatin-based interventions to muscles in advance of sarcopenia is also highly effective at preventing muscle atrophy associated with advanced aging29, further exploration of follistatin as a therapeutic for frailty associated with non-degenerative muscle wasting such as that which commonly impacts on the morbidity and mortality of aged citizens is supported.